D-Wave Quantum: IonQ's Tailwind Lifts Shares 6.6%, but Today's Q3 Report Is the Real Test

D-Wave Quantum closed Wednesday's session up 6.6%, carried higher by a broader quantum-computing rally after rival IonQ posted strong quarterly results and raised its revenue outlook, according to media reports. That sector-wide lift sets up a sharper question for shareholders ahead of Thursday's trading: how much of the optimism actually belongs to D-Wave's own business?

The company has scheduled its third-quarter 2026 results for release before the market opens, with a companion webcast set for 8:00 a.m. ET. The report lands as the first company-specific checkpoint since the stock's sector-driven advance, and it will go a long way toward determining whether investors treat the recent enthusiasm as borrowed momentum or as a genuine re-rating.

A Solver That Works Eight Times Faster

The clearest operational evidence D-Wave has offered recently came roughly a week ago, when it announced upgrades to its hybrid Stride solver. According to the company, the improved version produced better solutions within 15 seconds in benchmark tests than its predecessor managed in 120 seconds.

That comparison is against D-Wave's own earlier release, which makes it a meaningful but narrow claim. The real test is whether the speed advantage holds up on the problems prospective customers actually need solved. Alongside the solver upgrade, D-Wave launched "Applied Quantum Optimization," a three-course learning path aimed at developers. Pairing a faster tool with training is a logical combination — a technology spreads only when people know how to use it — but the payoff depends on whether developers carry what they learn into live applications.

LG CNS: An MOU, Not Yet a Contract

A second thread runs through the company's partnership with LG CNS, announced about two weeks ago. The two firms signed a non-binding memorandum of understanding to advance quantum computing for enterprise optimization tasks, with a geographic focus on South Korea and international markets.

The word "non-binding" matters for anyone weighing the deal's economic significance. The arrangement could support D-Wave's push toward wider adoption, but only if the intent translates into concrete joint activity. Until then, its value is potential rather than realized.

Shionogi's NEDO Win and a 94.31% Simulation

Customer research offers another angle. Work by D-Wave client Shionogi on drug discovery using quantum computing took first place in the quality-of-life category of the NEDO Challenge on October 28, with the prize money earmarked to fund further research. Separately, researchers at Florida Atlantic University reported a lung-cancer prediction method built on D-Wave's annealing technology that reached 94.31% accuracy in simulation and 91.90% on quantum hardware.

Both results are encouraging, and both carry caveats. The lung-cancer announcement explicitly described its findings as preliminary and pointed to an expanded dataset. Whether such research matures into durable, usable methods — and how long that takes — remains an open question that investors would need to price in.

What the Revenue Line Must Show

Against that backdrop, the revenue figure in today's report becomes the decisive metric. It is the clearest signal of whether commercial use of D-Wave's offerings is actually developing, and it will determine how much weight the market assigns to sector optimism versus the company's own execution.

The bull case gains substance if product improvements, developer training and partnerships show up in the business. If operating progress lags expectations for commercialization, a more cautious read of the industry tailwind would be warranted. Faster tools and a broader curriculum point in the right direction — but the connection between better offerings and a sustainable business is what today's numbers must begin to prove.